Skip to content

First Tracks Biotherapeutics vs Taiwan Semiconductor Manufacturing Company Limited

A head-to-head of First Tracks Biotherapeutics (TRAX) and Taiwan Semiconductor Manufacturing Company Limited (TSMWF) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.

MetricTRAXTSMWF
Market Cap$696.71M$447.07B
P/E (TTM)8.52
Forward P/E0.0014.71
P/S0.000.11
P/B2.102.70
EV/EBITDA0.009.34
Dividend Yield3.23%
Profit Margin0.00%44.57%
Gross Margin59.89%
Operating Margin0.00%50.83%
Revenue Growth (YoY)0.00%+20.45%
FCF Yield221.97%
Debt / Equity16.73
Current Ratio10.782.51

Which is better: First Tracks Biotherapeutics or Taiwan Semiconductor Manufacturing Company Limited?

  • Larger by market cap: Taiwan Semiconductor Manufacturing Company Limited
  • More profitable (net margin): Taiwan Semiconductor Manufacturing Company Limited
  • Faster revenue growth: Taiwan Semiconductor Manufacturing Company Limited

Across 5 available metrics, Taiwan Semiconductor Manufacturing Company Limited leads 3–2.

There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.

Share:

Compare First Tracks Biotherapeutics with others

This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.